eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

Background: Evidence from clinical practice on the effects of switching from emtricitabine/tenofovir disoproxil fumarate (F/TDF) to emtricitabine/tenofovir alafenamide (F/TAF)-based triple-therapy (TT) regimens on renal parameters is limited. Objective: This retrospective analysis evaluated the effe...

Full description

Bibliographic Details

Published in:	HIV Research & Clinical Practice
Main Authors:	Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Josefa Muñoz, Pepa Galindo, MaríaDolores Merino, Belén de la Fuente, María Antonia Sepúlveda, Pere Domingo, Josefina García, Manuel Castaño, Esteve Ribera, Paloma Geijo, Alberto Romero, Joaquim Peraire, Elisabeth Deig, Bernardino Roca, Elisa Martínez, Vicente Estrada, Marta Montero, Juan Berenguer, Nuria Espinosa
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-09-01
Subjects:	hiv estimated glomerular filtration rate emtricitabine tenofovir disoproxil fumarate tenofovir alafenamide switch retrospective
Online Access:	http://dx.doi.org/10.1080/25787489.2021.1955197